Red blood cell supernatant induces regulatory t cells independent of leukoreduction or free hemoglobin

2008 ◽  
Vol 207 (3) ◽  
pp. S42
Author(s):  
Joel M. Baumgartne ◽  
Ernest E. Moore ◽  
Anirban Banerjee ◽  
Christopher Silliman ◽  
Martin McCarter
2009 ◽  
Vol 208 (1) ◽  
pp. 110-119 ◽  
Author(s):  
Joel M. Baumgartner ◽  
Christopher C. Silliman ◽  
Ernest E. Moore ◽  
Anirban Banerjee ◽  
Martin D. McCarter

Author(s):  
Shannon L. McArdel ◽  
Anne-Sophie Dugast ◽  
Maegan E. Hoover ◽  
Arjun Bollampalli ◽  
Enping Hong ◽  
...  

AbstractRecombinant agonists that activate co-stimulatory and cytokine receptors have shown limited clinical anticancer utility, potentially due to narrow therapeutic windows, the need for coordinated activation of co-stimulatory and cytokine pathways and the failure of agonistic antibodies to recapitulate signaling by endogenous ligands. RTX-240 is a genetically engineered red blood cell expressing 4-1BBL and IL-15/IL-15Rα fusion (IL-15TP). RTX-240 is designed to potently and simultaneously stimulate the 4-1BB and IL-15 pathways, thereby activating and expanding T cells and NK cells, while potentially offering an improved safety profile through restricted biodistribution. We assessed the ability of RTX-240 to expand and activate T cells and NK cells and evaluated the in vivo efficacy, pharmacodynamics and tolerability using murine models. Treatment of PBMCs with RTX-240 induced T cell and NK cell activation and proliferation. In vivo studies using mRBC-240, a mouse surrogate for RTX-240, revealed biodistribution predominantly to the red pulp of the spleen, leading to CD8 + T cell and NK cell expansion. mRBC-240 was efficacious in a B16-F10 melanoma model and led to increased NK cell infiltration into the lungs. mRBC-240 significantly inhibited CT26 tumor growth, in association with an increase in tumor-infiltrating proliferating and cytotoxic CD8 + T cells. mRBC-240 was tolerated and showed no evidence of hepatic injury at the highest feasible dose, compared with a 4-1BB agonistic antibody. RTX-240 promotes T cell and NK cell activity in preclinical models and shows efficacy and an improved safety profile. Based on these data, RTX-240 is now being evaluated in a clinical trial.


2003 ◽  
Vol 94 (1) ◽  
pp. 38-42 ◽  
Author(s):  
R. D. Telford ◽  
G. J. Sly ◽  
A. G. Hahn ◽  
R. B. Cunningham ◽  
C. Bryant ◽  
...  

There is a wide body of literature reporting red cell hemolysis as occurring after various forms of exercise. Whereas the trauma associated with footstrike is thought to be the major cause of hemolysis after running, its significance compared with hemolysis that results from other circulatory stresses on the red blood cell has not been thoroughly addressed. To investigate the significance of footstrike, we measured the degree of hemolysis after 1 h of running. To control for the potential effects of oxidative and circulatory stresses on the red blood cell, the same subjects cycled for 1 h at equivalent oxygen uptake. Our subjects were 10 male triathletes, who each completed two separate 1-h sessions of running and cycling at 75% peak oxygen uptake, which were performed in random order 1 wk apart. Plasma free hemoglobin and serum haptoglobin concentrations were measured as indicators of hemolysis. We also measured methemoglobin as a percentage of total hemoglobin immediately postexercise as an indicator of red cell oxidative stress. Plasma free hemoglobin increased after both running ( P < 0.01) and cycling ( P < 0.01), but the increase was fourfold greater after running ( P < 0.01). This was reflected by a significant fall in haptoglobin 1 h after the running trials, whereas no significant changes occurred after cycling at any sample point. Methemoglobin increased twofold after both running and cycling ( P < 0.01), with no significant differences between modes of exercise. The present data indicate that, whereas general circulatory trauma to the red blood cells associated with 1 h of exercise at 75% maximal oxygen uptake may result in some exercise-induced hemolysis, footstrike is the major contributor to hemolysis during running.


Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 2325-2325
Author(s):  
Tamir Kanias ◽  
Janet Lee ◽  
Mark H. Yazer ◽  
Darrell J Triulzi ◽  
Ashley Lippert ◽  
...  

Abstract Abstract 2325 Red blood cell (RBC) hemolysis during hypothermic storage is a principal criterion for assessing the quality of RBC units. The presence of free hemoglobin in RBC units can promote post transfusion injuries, such as vascular dysfunction, via accelerated nitric oxide scavenging and reactive oxygen species. It has been noted in clinical practice that specific donor red cell units are more likely to hemolyze during storage, and that female gender is associated with less hemolysis following 42 days of hypothermic storage, and during experimental mechanical stress. These findings lead us to our overarching hypothesis that genetic variations, including gender, modulate the propensity of RBCs to hemolyze under diverse stressors that may be maximized during red blood cell storage. This study further examines the relationship between gender and hemolysis in human and mouse RBCs. Washed RBCs were obtained from RBC units stored in ADSOL for short (3–10 days old) or long (42–47 days old, expired units) time periods. The donors' age averaged 43.9±14.8 and 39.3±14.6 years, women versus men, respectively. RBCs were also obtained from 10-week-old C57BL/6J male and female mice and stored for 3 days in phosphate buffered saline. Hemolytic propensity was assessed by various stressors validated in our laboratory for 96-well plate high throughput assays. Osmotic stress was induced by incubating RBCs in hypotonic buffer containing glycerol. Oxidative hemolysis was induced by 2,2'-azobis (2-methylpropionamidine) dihydrochloride (AAPH). Mechanical stress was achieved by shaking RBC suspensions in the presence of a 3/32” stainless steel bead over 90 minutes. Percent hemolysis was measured by supernatant cell-free hemoglobin using Drabkin's assay. Hemolysis levels (%) in response to osmotic stress were significantly (p=0.0108, Mann-Whitney test) lower in RBCs donated by women and stored for 8±2 days (16±7.1 % versus 24±7.3 % in men, n=14). This difference was also observed in expired units (31±6.0 % versus 40±6.1 % in men, n=12-16, p=0.0017). The mechanical fragility index (MFI) of premenopausal women RBCs stored for 10 days was significantly (p=0.0286) lower than that of men from a matched age group (MFI= 7.3±0.9 versus 9.4±1, respectively; n=4). Conversely, women RBC response to AAPH-induced oxidative hemolysis treatment was similar to that of men (49±4.8 % versus 48±4.7 %, respectively, n=14). Similar assays done in C57BL/6J mice revealed that female RBCs hemolyze less in response to osmotic stress (60±5.6 % versus 69±8.4 % in males, n=10, p=0.0435) or AAPH treatments (58±6 % versus 65±3.3 % in males, n=10, p=0.0106). These gender differences became noticeable after 2–3 days of storage in PBS. Our study correlates gender with the propensity of RBCs to hemolyse under various stresses in human and mouse. It implies that under the tested conditions, RBCs collected by women are more resilient to mechanical and osmotic stresses, whereas female mouse RBCs exhibit higher resistance to osmotic and AAPH-induced oxidative stress compared with males. The mechanisms of this phenomenon are yet to be resolved and may be related to estrogen protective effects in reproductive females. Our experimental model suggests that gender differences are intrinsic to the RBC, as cells were washed and plasma or additive solution was removed. Understanding the molecular mechanisms of hemolysis can contribute to the process of RBC donor screening, reduce storage hemolysis, and possibly post-transfusion complications. Disclosures: Gladwin: Patents filed related to treating hemolysis.: Patents & Royalties.


1985 ◽  
Vol 76 (3) ◽  
pp. 433-439 ◽  
Author(s):  
A.I. Levinson ◽  
J.A. Hoxie ◽  
M.J. Kornstein ◽  
D. Zembryki ◽  
D.M. Matthews ◽  
...  

Blood ◽  
2011 ◽  
Vol 118 (26) ◽  
pp. 6952-6962 ◽  
Author(s):  
Giulia Costa ◽  
Séverine Loizon ◽  
Marianne Guenot ◽  
Iulia Mocan ◽  
Franck Halary ◽  
...  

AbstractThe control of Plasmodium falciparum erythrocytic parasite density is essential for protection against malaria, because it prevents pathogenesis and progression toward severe disease. P falciparum blood-stage parasite cultures are inhibited by human Vγ9Vδ2 γδ T cells, but the underlying mechanism remains poorly understood. Here, we show that both intraerythrocytic parasites and the extracellular red blood cell–invasive merozoites specifically activate Vγ9Vδ2 T cells in a γδ T cell receptor–dependent manner and trigger their degranulation. In contrast, the γδ T cell–mediated antiparasitic activity only targets the extracellular merozoites. Using perforin-deficient and granulysin-silenced T-cell lines, we demonstrate that granulysin is essential for the in vitro antiplasmodial process, whereas perforin is dispensable. Patients infected with P falciparum exhibited elevated granulysin plasma levels associated with high levels of granulysin-expressing Vδ2+ T cells endowed with parasite-specific degranulation capacity. This indicates in vivo activation of Vγ9Vδ2 T cells along with granulysin triggering and discharge during primary acute falciparum malaria. Altogether, this work identifies Vγ9Vδ2 T cells as unconventional immune effectors targeting the red blood cell–invasive extracellular P falciparum merozoites and opens novel perspectives for immune interventions harnessing the antiparasitic activity of Vγ9Vδ2 T cells to control parasite density in malaria patients.


Vox Sanguinis ◽  
1991 ◽  
Vol 61 (1) ◽  
pp. 14-17 ◽  
Author(s):  
T.J. Greenwalt ◽  
C.G. McGuiness ◽  
U.J. Dumaswala

Sign in / Sign up

Export Citation Format

Share Document